Oak Ridge Investments LLC Veracyte, Inc. Transaction History

Oak Ridge Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$15.45 - $29.52 $1.06 Million - $2.02 Million	-68,415 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$21.94 - $42.51 $865,160 - $1.68 Million	-39,433 Reduced 36.56%	68,415 $1.89 Million
Q4 2021 Feb 01, 2022	SELL	$36.09 - $53.79 $65,611 - $97,790	-1,818 Reduced 1.66%	107,848 $4.44 Million
Q3 2021 Nov 05, 2021	SELL	$35.62 - $52.97 $131,081 - $194,929	-3,680 Reduced 3.25%	109,666 $5.09 Million
Q2 2021 Jul 30, 2021	SELL	$32.94 - $56.62 $230,052 - $395,434	-6,984 Reduced 5.8%	113,346 $4.53 Million
Q1 2021 May 12, 2021	SELL	$44.47 - $81.38 $38.3 Million - $70.1 Million	-861,079 Reduced 87.74%	120,330 $6.47 Million
Q1 2021 May 04, 2021	SELL	$44.47 - $81.38 $5.53 Million - $10.1 Million	-124,370 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$32.49 - $61.88 $945,264 - $1.8 Million	-29,094 Reduced 18.96%	124,370 $6.09 Million
Q3 2020 Nov 12, 2020	BUY	$26.73 - $35.67 $4.1 Million - $5.47 Million	153,464 New	153,464 $4.99 Million

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Oak Ridge Investments LLC with notifications on news.